XML 58 R41.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Awards (Tables)
12 Months Ended
Dec. 31, 2024
Stock-Based Awards  
Schedule of Assumptions Used to Determine Fair Value of Stock Options Granted to Employees and Directors Presented on Weighted Average Basis

Year Ended

 

December 31, 

 

    

2024

    

2023

    

2022

 

Risk-free interest rate

 

4.11

%  

3.72

%  

2.10

%

Expected term (in years)

 

6.0

 

6.0

 

6.0

Expected volatility

 

80.12

%  

77.32

%  

81.14

%

Expected dividend yield

 

0.0

%  

0.0

%  

0.0

%

Schedule of Stock Option Activity

Weighted

Weighted

Average

Average

Remaining

Aggregate

Shares Issuable

Exercise

Contractual

Intrinsic

    

Under Options

    

Price

    

Term

    

Value

(In years)

Outstanding as of December 31, 2023

 

16,136,791

$

7.51

 

6.10

$

3,364

Granted

 

9,207,383

 

7.62

 

Exercised

 

(3,112,976)

 

4.74

 

Cancelled/forfeited

 

(2,343,515)

 

8.07

 

Outstanding as of December 31, 2024

 

19,887,683

$

7.93

 

6.05

$

41,570

Options vested and expected to vest as of December 31, 2024

 

18,406,424

$

8.10

 

5.89

$

37,139

Options exercisable as of December 31, 2024

 

11,419,466

$

8.26

 

3.90

$

27,814

Schedule of Restricted Stock Activity

 

Weighted

 

average

 

grant date

 

    

RSU's

    

fair value

 

 

Unvested balance at December 31, 2023

 

1,627,341

$

4.40

Granted

 

3,628,824

 

7.89

Released

(1,277,398)

5.84

Cancelled/forfeited

 

(589,163)

 

4.79

Unvested balance at December 31, 2024

 

3,389,604

$

7.52

Schedule of stock-based compensation expense related to stock options

Year Ended December 31, 

    

2024

    

2023

    

2022

    

Research and development

$

9,276

$

4,508

$

4,166

Selling and marketing

 

3,071

 

3,682

 

4,684

General and administrative

 

20,762

 

9,635

 

8,114

$

33,109

$

17,825

$

16,964